300
Participants
Start Date
January 1, 2019
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2030
DTG+ 3TC
It is a simplified therapy regimen study of dolutegravir combined with lamivudine for HIV-1 infected patients in the real world of China.
RECRUITING
Guangzhou 8th People's Hospital, Guangzhou
Shenzhen Third People's Hospital
OTHER
Dongguan People's Hospital
OTHER_GOV
Fifth Affiliated Hospital, Sun Yat-Sen University
OTHER
The Third People's Hospital of Guilin
UNKNOWN
Guangxi Longtan hospital
UNKNOWN
The Fourth People's Hospital of Nanning
OTHER
The Third People's Hospital of Kunming
UNKNOWN
Yunnan AIDS Care Center
OTHER
Meng Chao Hepatobiliary Hospital of Fujian Medical University
OTHER
First Affiliated Hospital of Guangxi Medical University
OTHER
Guangzhou 8th People's Hospital
OTHER